Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of the Covid-19 pandemic on breast cancer early detection and screening.
Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium; Figueroa JD, Gray E, Pashayan N, Deandrea S, Karch A, Vale DB, Elder K, Procopio P, van Ravesteyn NT, Mutabi M, Canfell K, Nickson C. Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium, et al. Among authors: van ravesteyn nt. Prev Med. 2021 Oct;151:106585. doi: 10.1016/j.ypmed.2021.106585. Epub 2021 Jun 30. Prev Med. 2021. PMID: 34217412 Free PMC article.
Transition from film to digital mammography: impact for breast cancer screening through the national breast and cervical cancer early detection program.
van Ravesteyn NT, van Lier L, Schechter CB, Ekwueme DU, Royalty J, Miller JW, Near AM, Cronin KA, Heijnsdijk EA, Mandelblatt JS, de Koning HJ. van Ravesteyn NT, et al. Among authors: van lier l. Am J Prev Med. 2015 May;48(5):535-42. doi: 10.1016/j.amepre.2014.11.010. Am J Prev Med. 2015. PMID: 25891052 Free PMC article.
The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe.
Gini A, van Ravesteyn NT, Jansen EEL, Heijnsdijk EAM, Senore C, Anttila A, Novak Mlakar D, Veerus P, Csanádi M, Zielonke N, Heinävaara S, Széles G, Segnan N, de Koning HJ, Lansdorp-Vogelaar I; EU-TOPIA consortium. Gini A, et al. Among authors: van ravesteyn nt. Prev Med Rep. 2021 Apr 30;22:101392. doi: 10.1016/j.pmedr.2021.101392. eCollection 2021 Jun. Prev Med Rep. 2021. PMID: 34026466 Free PMC article.
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.
van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS. van Ravesteyn NT, et al. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):112-22. doi: 10.1158/1055-9965.EPI-10-0944. Epub 2010 Nov 30. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21119071 Free PMC article.
Effects of cancer screening restart strategies after COVID-19 disruption.
Kregting LM, Kaljouw S, de Jonge L, Jansen EEL, Peterse EFP, Heijnsdijk EAM, van Ravesteyn NT, Lansdorp-Vogelaar I, de Kok IMCM. Kregting LM, et al. Among authors: van ravesteyn nt. Br J Cancer. 2021 Apr;124(9):1516-1523. doi: 10.1038/s41416-021-01261-9. Epub 2021 Mar 15. Br J Cancer. 2021. PMID: 33723386 Free PMC article.
78 results